SciBase reaches milestone with over 400,000 tests sold with Nevisense

STOCKHOLM, April 7, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant milestone with over 400,000 Nevisense tests sold worldwide. Nevisense is the only FDA-approved and...